EU trade groups discuss value-based healthcare

20 February 2019
efpia-big-3

Today, APIFARMA (the Portuguese Pharmaceutical Industry Association), ICHOM (the International Consortium for Health Outcomes Measurement) and EFPIA (the European Federation of Pharmaceutical Companies and Associations) are hosting a full-day seminar in Lisbon on how the consistent measurement of outcomes can improve care for patients.

The workshop is an opportunity to discuss how to put outcomes-based healthcare into practice at national level to deliver more for patients while making healthcare systems more financially sustainable.

Speaking on behalf of APIFARMA, João Almeida Lopes argues that "better results in Health are a common goal for all health stakeholders, in Europe and Portugal." The president of the APIFARMA board says: "We have to progress, for the benefit of patients and health system sustainability, to a methodology that optimizes the results in Health.” Therefore we place “the patient at the center of the system while fostering for a more humanistic and sustainable healthcare model", he concludes.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical